← Evidence map

ArticleAging2023

HYDIN mutation status as a potential predictor of immune checkpoint inhibitor efficacy in melanoma.

Liu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37595251